tickrz reports
tickrz rank
A
Aetna Inc (AET)
Healthcare | Health Services
156.41  -2.81%
FACTOR RANKINGSFACTOR SCREENER 
tickrz RankA / 110Warren Buffett RankA / 100
Pure Value RankB / 170Dividend RankA / 57
Moat RankC / 265Financial Strength RankN/A
Growth RankA / 100Momentum RankA / 70
AET vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
AETSECTORS&P 500
P/E RATIO34.5632.119.28
EV/EBITDA RATIO8.321711.77
P/S RATIO0.873.62.03
P/B RATIO3.515.53.09
QUALITY
RETURN ON EQUITY9.17%15.64%13.82%
RETURN ON CAPITAL%50.61%10.04%
NET MARGIN3.59%8.18%9.76%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.92%
PAYOUT RATIO19.23%
3 YR DIVIDEND GROWTH6.62%
FINANCIAL STRENGTH
F SCORE NOT AVAILABLE
DEBT-TO-EQUITY59%
INTEREST COVERAGEN/Ax
CURRENT RATIO0.79
GROWTH
5 YR EPS GROWTH4.19%
5 YR SPS GROWTH13.34%
5 YR BPS GROWTH11.93%
About tickrz
Key Concepts
Great Investors
tickrz A-Ranked Aetna Inc places highly in the Health Services industry
tickrz rank A / 110
Aetna Inc receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
value
pure value ranking B / 170Warren Buffett ranking A / 100
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Aetna Inc's valuation score is comprised of a P/E ratio of 34.6x, a P/B ratio of 3.5x, a P/S ratio of 0.9x, and an EV/EBITDA ratio of 8.3x. Aetna Inc ranks 170 out of the S&P 500 constituents on valuation--a relatively average score.Aetna Inc ranks 100 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Aetna Inc warrants further investigation.

quality
moat C / 265financial strength N/A
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Healthcare sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.A debt/equity ratio of 59% and a Moat Rank of 265 translate to a not available Financial Strength score.


momentum A / 70
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 36.12% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 70. Aetna Inc's strong 12 month stock performance will appeal to momentum investors.

yield A / 57
value + yield
Shares currently yield 0.92%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Aetna Inc ranks 57 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will want to closely investigate Aetna Inc.

growth A / 100
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 4.2% 5 year annualized EPS growth, 13.3% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 11.9% speak to its impressive growth ranking.

Aetna Inc (AET)
Healthcare | Health Services
156.41  -2.81%


tickrz rank
A
VALUATION RATIOS
P/E Ratio34.56x
P/B Ratio3.51x
P/S Ratio0.87x
EV/EBITDA Ratio8.32x
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.92%
PAYOUT RATIO19.23%
3 YR DIVIDEND GROWTH6.62%
FINANCIAL STRENGTH
F SCORE NOT AVAILABLE
DEBT-TO-EQUITY59%
INTEREST COVERAGEN/Ax
CURRENT RATIO0.79
MOAT
ROE9.17%
ROIC
Net Margin3.59%
GROWTH
5 YR EPS GROWTH4.19%
5 YR SPS GROWTH13.34%
5 YR BPS GROWTH11.93%

TICKRZ RANK
Aetna Inc receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Aetna Inc's valuation score is comprised of a P/E ratio of 34.6x, a P/B ratio of 3.5x, a P/S ratio of 0.9x, and an EV/EBITDA ratio of 8.3x. Aetna Inc ranks 170 out of the S&P 500 constituents on valuation--a relatively average score.

WARREN BUFFETT RANKING
Aetna Inc ranks 100 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Aetna Inc warrants further investigation.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Healthcare sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.

FINANCIAL STRENGTH
A debt/equity ratio of 59% and a Moat Rank of 265 translate to a not available Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 36.12% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 70. Aetna Inc's strong 12 month stock performance will appeal to momentum investors.

VALUE + YIELD
Shares currently yield 0.92%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Aetna Inc ranks 57 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will want to closely investigate Aetna Inc.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 4.2% 5 year annualized EPS growth, 13.3% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 11.9% speak to its impressive growth ranking.